In a world-first international trial, adding intismeran, a type of personalized therapeutic cancer vaccine made from each patient's own tumor, to pembrolizumab immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or …

People with multiple sclerosis (MS) who are treated with rituximab have an increased risk of developing inflammatory bowel disease, particularly Crohn's disease, although the absolute risk remains low. This is according to the first large popula…

A single tooth can contain valuable clues to a person's identity, even when remains are severely decomposed or reduced to bones, according to a study by researchers at the Institute of Science Tokyo. By applying multiple forensic methods to diff…

A new biological model published in Sexual Medicine Reviews by Oxford University Press addresses why pain during sex after childbirth—reported by 60% of women at three months—persists for some long after hormones return to normal. Developed by Dr. L…

A modeling study suggests that replacing universal hepatitis B vaccination at birth with delayed vaccination or a shared decision-making approach, as recommended by the U.S. federal government this year, could lead to substantially more chronic hepa…

People who are marginalized or lack access to a primary care provider are at greater risk of early death from newly diagnosed (de novo) metastatic breast cancer, according to research in the Canadian Medical Association Journal. from Medical Xpres…

A large-scale study, presented at UEG Week 2026, has identified distinct antibody patterns up to 10 years before the diagnosis of inflammatory bowel disease (IBD), potentially opening new avenues for earlier risk detection and providing insights int…